The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.

Source:http://linkedlifedata.com/resource/pubmed/id/14742994

Transplantation 2004 Jan 27 77 2 281-6

Download in:

View as

Triples

General Info

PMID
14742994